and Re-emerging Pathogens and chairs the Recombinant DNA Subcommittee of the university’s Institutional Biosafety Committee. She chairs the National Institutes of Health’s Center for Scientific Review Study Section BM-1, which reviews bacterial-pathogenesis submissions to the National Institute of Allergy and Infectious Diseases. Dr. Connell’s involvement in biological weapons control began in 1984, when she was chair of the Committee on the Military Use of Biological Research, a subcommittee of the Council for Responsible Genetics, based in Cambridge, Massachusetts. Dr. Connell received her Ph.D. in microbiology from Harvard University. Her major research focus is the interaction between Mycobacterium tuberculosis and the macrophage.
Philip E. Coyle III, Science Strategies
Mr. Coyle served as assistant secretary of defense and director of operational test and evaluation at the Department of Defense (DOD). In this capacity he was principal adviser to the secretary of defense and the under secretary of defense for acquisition, technology, and logistics of testing and evaluation. Mr. Coyle has 30 years of experience in testing and test-related matters. From 1959 to 1979 and 1981 to 1993, he worked at the Lawrence Livermore National Laboratory in Livermore, California, where he served as an associate director. During the Carter administration, he served as principal deputy assistant secretary for defense programs in the Department of Energy, in which capacity he had oversight responsibility for the nuclear-weapons testing programs of the department. The International Test and Evaluation Association awarded Mr. Coyle the Allan R. Matthews Award, its highest award, for his contributions to the management and technology of testing and evaluation. Mr. Coyle was awarded the Defense Distinguished Service Medal by DOD Secretary Perry and the Bronze Palm of the Defense Distinguished Service Medal by DOD Secretary Cohen. Mr. Coyle received a B.A. and an M.S. in mechanical engineering from Dartmouth University.
Eric Eisenstadt, J. Craig Venter Institute
Dr. Eisenstadt is deputy vice-president for research at the J. Craig Venter Institute. Dr. Eisenstadt, whose background is in microbial physiology and genetics, has cultivated interdisciplinary programs in biotechnology for the past 17 years at the Defense Advanced Research Projects Agency, Defense Sciences Office and the Office of Naval Research Biological Science and Technology Division. As a program manager at DARPA and ONR, Dr. Eisenstadt developed and managed diverse research in which interdisciplinary teams analyzed single-cell gene regulatory networks, sequenced biological warfare microbes, created computational tools for the de novo design of novel proteins, and explored biofabrication’s potential in high-efficiency solar cells. He was the Navy’s technical representative to the joint services program for basic and applied research programs in chemical and biologicalwarfare defense. Dr. Eisenstadt received his Ph.D. in biology from Washington University.
Eric E. Gard, Lawrence Livermore National Laboratory
Dr. Gard, a chemist, leads the Lawrence Livermore National Laboratory’s Defense Biology Division, where he has worked for the past six years to develop a system that can detect airborne pathogens and sound a warning in less than a minute. He and his team have answered that challenge by developing the Bioaerosol Mass Spectrometry system, which won a 2005 research and development 100 award as one of the year’s most promising technologies and is now available for licensing. Dr. Gard received his Ph.D. from the University of California, Davis.